Abstract:TNF-receptor-associated factors (TRAFs) are intracellular proteins that bind to the cytoplasmic portion of TNF receptors and mediate downstream signaling. The six known TRAF proteins play overlapping yet distinct roles in controlling immune responses as well as cellular processes such as activation of NF-κB and JNK signaling pathways. For example, CD40 binds to TRAF2, TRAF3 and TRAF6 to control B cell differentiation, proliferation and growth.1 In contrast, binding of lymphotoxin-β receptor (LTβR) to TRAF2 and TRAF5 propagates signals leading to activation of NF-κB,2 while binding to TRAF3 induces negative regulation of this pathway and leads to apoptosis in tumor cells.3,4 Binding recognition is mediated by specific contacts of a consensus recognition sequence in the partner with residues in a hydrophobic crevice on the TRAF molecule. Since each of these protein-protein interactions occurs within this same binding crevice, it appears that TRAF-mediated cellular mechanisms may be regulated, in part, by the level of expression or recruitment of the adaptor proteins or receptors that are competing for the crevice.The specific contacts of CD40, LTβR and BAFF-R have been defined in crystal structures of the complex with TRAF3.5–7 In addition, the downstream regulator TANK and the viral oncogenic protein LMP1 from the Epstein Barr virus also bind to the same TRAF crevice and these contacts have also been described crystallographically.8,9 Comparison of these five crystal structures has revealed that the recognition motifs in each of these proteins are accommodated in one TRAF3 binding crevice and that the binding interface is structurally and functionally adaptive.10 In this chapter, the molecular details of the interactions will be described and correlated with the functional implications for multiple TRAF3 roles in cellular regulation.

TRAF6 initiates inflammatory signaling via organizing membraneless cytoplasmic condensates

Cutting Edge: TRAF6 Mediates TLR/IL-1R Signaling–Induced Nontranscriptional Priming of the NLRP3 Inflammasome

ADP-Hep-Induced Liquid Phase Condensation of TIFA-TRAF6 Activates ALPK1/TIFA-Dependent Innate Immune Responses

The Evolving Role of TRAFs in Mediating Inflammatory Responses

Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and limits sepsis and rheumatoid arthritis

TRAF3-interacting JNK-activating Modulator Promotes Inflammation by Stimulating Translocation of Toll-like Receptor 4 to Lipid Rafts

Oligomerization-primed Coiled-Coil Domain Interaction with Ubc13 Confers Processivity to TRAF6 Ubiquitin Ligase Activity.

Protein-Protein Interactions in TRAF3

The relationship between TRAF6 and tumors

Regulation of TLR4 signaling through the TRAF6/sNASP axis by reversible phosphorylation mediated by CK2 and PP4

Physiological Roles and Mechanisms of Signaling by TRAF2 and TRAF5

TRAF2: a Double-Edged Sword?

RSK2 is Required for TRAF6 Phosphorylation-Mediated Colon Inflammation

Interleukin-17F Signaling Requires Ubiquitination of Interleukin-17 Receptor Via TRAF6.

A TLR4/TRAF6-dependent signaling pathway mediates NCoR coactivator complex formation for inflammatory gene activation

TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms

Toll like receptor 3 mediated activation of NF κB and IRF3 diverges at Toll IL 1 receptor domain containing adapter inducing IFN β

TRAF6 promotes IL-4-induced M2 macrophage activation by stabilizing STAT6

Phospho-Sxxe/D Motif Mediated Tnf Receptor 1-Tradd Death Domain Complex Formation For T Cell Activation And Migration